Metformin Hydrochloride Zentiva Pharma (Metformin Hydrochloride)

Metformin Hydrochloride is indicated for the management of type 2 diabetes mellitus, a chronic metabolic disorder characterized by insulin resistance and elevated blood glucose.

• Type 2 diabetes mellitus: Improves glycemic control by reducing hepatic glucose production and enhancing peripheral insulin sensitivity.

• Metformin Hydrochloride reduces hepatic gluconeogenesis by activating AMP‑activated protein kinase (AMPK), which inhibits key enzymes involved in glucose output. It also increases insulin‑mediated glucose uptake in muscle and adipose tissue, thereby lowering circulating blood glucose levels without stimulating insulin secretion.

Metformin Hydrochloride may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

• Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite.
• Diarrhea: frequent loose stools, especially during treatment initiation.
• Metallic taste: transient alteration in taste perception.
• Vitamin B12 deficiency: reduced absorption with long‑term use.

Serious or Rare Side Effects

• Lactic acidosis: a rare but life‑threatening accumulation of lactate.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatic dysfunction: abnormal liver enzymes indicating liver injury.
• Hypoglycemia: when combined with other glucose‑lowering agents.
• Pancreatitis: inflammation of the pancreas presenting with abdominal pain.

Metformin Hydrochloride requires careful patient assessment and monitoring to minimize risks.

• Renal function assessment: evaluate eGFR before initiating and periodically thereafter.
• Lactic acidosis risk: avoid in patients with severe renal impairment, hepatic disease, or conditions predisposing to hypoxia.
• Alcohol consumption: limit intake as excessive alcohol increases lactic acidosis risk.
• Pregnancy and lactation: use only if potential benefits outweigh risks.
• Drug interactions: review concomitant medications for possible interactions.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Metformin Hydrochloride can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
• Cimetidine: can raise metformin plasma concentrations, enhancing toxicity.
• Nitrates: combined use may cause severe hypotension.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask symptoms of hypoglycemia.
• Thiazide diuretics: can attenuate metformin’s glucose‑lowering effect.
• ACE inhibitors or ARBs: monitor renal function and electrolytes during co‑administration.